CN1276087C - Process for biologically synthesizing gamma-amino butyric acid - Google Patents
Process for biologically synthesizing gamma-amino butyric acid Download PDFInfo
- Publication number
- CN1276087C CN1276087C CN 200510049187 CN200510049187A CN1276087C CN 1276087 C CN1276087 C CN 1276087C CN 200510049187 CN200510049187 CN 200510049187 CN 200510049187 A CN200510049187 A CN 200510049187A CN 1276087 C CN1276087 C CN 1276087C
- Authority
- CN
- China
- Prior art keywords
- culture medium
- gyp
- seed culture
- mycelia
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 12
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title abstract description 17
- 229960003692 gamma aminobutyric acid Drugs 0.000 title abstract description 14
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title abstract 3
- 230000002194 synthesizing effect Effects 0.000 title abstract 2
- 230000008569 process Effects 0.000 title description 2
- 239000001963 growth medium Substances 0.000 claims abstract description 27
- 238000011218 seed culture Methods 0.000 claims abstract description 20
- 229940073490 sodium glutamate Drugs 0.000 claims abstract description 19
- 229920001817 Agar Polymers 0.000 claims abstract description 11
- 239000008272 agar Substances 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 239000002054 inoculum Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 7
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 7
- 239000002609 medium Substances 0.000 claims description 19
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 9
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 9
- AURFVNDXGLQSNN-UHFFFAOYSA-K trisodium 2-hydroxypropane-1,2,3-tricarboxylic acid phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O AURFVNDXGLQSNN-UHFFFAOYSA-K 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 230000003570 biosynthesizing effect Effects 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 abstract description 4
- 230000004151 fermentation Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 2
- 230000003139 buffering effect Effects 0.000 abstract 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 230000035484 reaction time Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 229960004249 sodium acetate Drugs 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 4
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000012531 culture fluid Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 102000004031 Carboxy-Lyases Human genes 0.000 description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007787 long-term memory Effects 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention discloses a method for biologically synthesizing gamma-amino butyric acid. The present invention is characterized in that after lactobacillus brevis whose the preservation number is CGMCC NO. 1306 is activated by an agar slant culture medium, the actobacillus brevis is inoculated to a GYP seed culture medium or an MRS seed culture medium; after the lactobacillus brevis is cultured for 10 to 30 hours, the lactobacillus brevis whose the inoculum size is from 0.5% to 5% is inoculated to a GYP fermentation culture medium or an MRS fermentation culture medium; at the temperature of 25 DEG C to 35 DEG C, after the lactobacillus brevis is cultured for 48h to 120h without moving, fermentation liquor containing mycelia can be obtained; the mycelia are collected in a centrifugal separating mode; the centrifugated mycelia are washed by deionized water which is sterilized; 0.25 to 2g of wet mycelia are taken and are suspended in 15 to 50mL of a citric acid-disodium hydrogen phosphate buffering system, wherein the content of L-sodium glutamate is from 5mM to 60mM, and the reaction time is from 1 to 10 hours; after the reaction solution is centrifugated, solution containing the gamma-amino butyric acid is obtained. The method has the advantages of low production cost, moderate reaction condition, little environment pollution, simple method, easy operation, high productive efficiency, high product purity, and the lightening of subsequent separation and purification processes.
Description
Technical field
The present invention relates to a kind of method of biosynthesizing γ-An Jidingsuan.
Background technology
γ-An Jidingsuan (being called for short GABA) is a kind of nonprotein amino acid with important physiologically active, is the important neurotransmitter of central nervous system.The lot of documents report, GABA has hypotensive and cholesterol, reduces neuronal activity, prevent that neurocyte is overheated, not only having and calming the nerves and resist the depressed effect that removes, and can also cerebral function improvement and long-term memory, increase growth hormone secretion, prevent obesity, the sharp kidney of strong liver, improve function such as climacteric syndrome.Along with the research that deepens continuously to the GABA physiologically active, the physiological function of the γ-An Jidingsuan that current research is found is more and more.GABA also has been subjected to more concern more and more, though GABA extensively exists in vivo, no matter in the animal and plant, content is but all very low, separates very difficultly, need synthesize preparation to it.Synthesis preparation method for it mainly contains chemical synthesis and biosynthetic means.Compare with chemical synthesis process, the synthetic GABA of biological process utilizes biological intravital L-Glutamic decarboxylase as catalyzer, is substrate with L-Sodium Glutamate (L-MSG), with L-Sodium Glutamate (L-MSG) α-decarboxylation, produces γ-An Jidingsuan and CO
2, major advantage is the synthesis condition gentleness, does not need expensive starting material, and environmental pollution is little, and energy consumption is little.One of key that adopts the synthetic GABA of biological process is exactly to filter out the strain excellent with high glutamic acid decarboxylase activity.Bibliographical information is arranged, the biosynthesizing of GABA adopts intestinal bacteria as producing bacterial strain usually, but have the hidden danger of food safety and sanitation aspect with intestinal bacteria as producing bacterial strain, this laboratory screening has the lactobacillus strain of the synthetic GABA ability of high-performance bio to a strain.This paper has reported the method for a kind of biosynthesizing GABA.
Summary of the invention
The method that the purpose of this invention is to provide a kind of biosynthesizing γ-An Jidingsuan.
Deposit number is: the short lactobacillus of CGMCC NO.1306 (Lactobacillus brevis), after the agar slant culture-medium activation, transfer in GYP seed culture medium or MRS seed culture medium, cultivate after 10～30 hours, inoculum size with 0.5%～5% is inoculated in GYP or the MRS fermention medium, leave standstill under 25 ℃～35 ℃ and cultivate 48h～120h, promptly get the fermented liquid of mycetome, the thalline centrifugation is collected; Thalline after centrifugal is again with the deionized water wash of the bacterium of going out, get 0.25～2g wet thallus, be suspended in citric acid-Sodium phosphate dibasic buffer system of 15～50mL, L-Sodium Glutamate content is 5mM～60mM, reacted the centrifugal solution that contains γ-An Jidingsuan that promptly gets of reaction solution 1～10 hour.
Deposit number is: the short lactobacillus of CGMCC NO.1306 (Lactobacillus brevis), and lactic acid producing when fermentation, microscopic examination is paired or become chain to occur, do not move, no spore, bacterium colony is little, smooth surface; Belong to gram positive bacterial strain, amphimicrobian.
The present invention adopts short lactobacillus as bacterial classification, thalli growth reaches stationary phase, collecting thalline, adopt whole-cell catalytic, is substrate with L-Sodium Glutamate (L-MSG), with citric acid-Sodium phosphate dibasic is buffer system, do not have other medium components such as other carbon nitrogen source, utilize the lactic acid thalline to contain the high reactivity L-Glutamic decarboxylase, L-Sodium Glutamate (L-MSG) α-decarboxylation, produce γ-An Jidingsuan, GABA output reaches 1～6g/L.The advantage of present method is that production cost is low, reaction conditions is gentle, environmental pollution is little, method is simple, easy handling, and the cycle is short, production efficiency is high, and product purity is higher, has alleviated the later separation purifying process.
Embodiment
A. bacterial strain
This laboratory screening.
B. substratum
1000mL agar slant storage medium: glucose 10g, yeast extract paste 10g, peptone 5g, sodium acetate 2g, MgSO
47H
2O 20mg, MnSO
44H
2O 1mg, NaCl 1mg, FeSO
47H
2O 1mg, agar 15g, pH 6.8.
1000mL GYP seed culture medium: glucose 10g, yeast extract paste 10g, peptone 5g, sodium acetate 2g, MgSO
47H
2O 20mg, MnSO
44H
2O 1mg, NaCl 1mg, FeSO
47H
2O 1mg, pH 6.6-7.0.
1000mL GYP fermention medium: glucose 10g, yeast extract paste 10g, peptone 5g, sodium acetate 2g, MgSO
47H
2O 20mg, MnSO
44H
2O 1mg, NaCl 1mg, FeSO
47H
2O 1mg, a hydration L-Sodium Glutamate 10g, pH 6.6-7.0.
1000mL MRS seed culture medium: extractum carnis 10g, yeast extract paste 5g, peptone 10g, K
2HpO
42g, ammonium citrate 2g, glucose 20g, tween-80 1mL, sodium-acetate 5g, inorganic salt solution 5mL (MgSO
47H
2O, 11.5%; MnSO
42H
2O, 2.4%), pH 6.6.
1000mL MRS fermention medium: extractum carnis 10g, yeast extract paste 5g, peptone 10g, K
2HPO
42g, ammonium citrate 2g, glucose 20g, tween-80 1mL, sodium-acetate 5g, inorganic salt solution 5mL (MgSO
47H
2O, 11.5%; MnSO
42H
2O, 2.4%), a hydration L-Sodium Glutamate 10g, pH 6.6.
C. preparation technology
This bacterial strain is after the agar slant culture-medium activation, transfer in GYP seed culture medium or MRS seed culture medium, cultivate after 10～30 hours, inoculum size inoculation GYP or MRS fermention medium with 0.5%～5%, under 30 ℃, leave standstill and cultivate 48h～120h, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is again with the deionized water wash of the bacterium of going out, get 0.25～2g wet thallus, be suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 5mM-100mM, reacted the centrifugal solution that contains γ-An Jidingsuan that promptly gets of reaction solution 1～10 hour.
This bacterial strain is after the agar slant culture-medium activation, transfer in GYP seed culture medium or MRS seed culture medium, cultivate after 10～30 hours, inoculum size inoculation GYP or MRS fermention medium with 0.5%～5%, under 30 ℃, leave standstill and cultivate 48h～120h, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is again with the deionized water wash of the bacterium of going out, get 0.25～2g wet thallus, be suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 5mM-100mM, reacted the centrifugal solution that contains γ-An Jidingsuan that promptly gets of reaction solution 1～10 hour.
Embodiment 1
This bacterial strain is after the agar slant culture-medium activation, transfer in the GYP seed culture medium, incubation time is 24 hours, seed culture fluid is inoculated in the GYP fermention medium with 1% inoculum size, adds a hydration L-Sodium Glutamate of 1% in the fermention medium, the liquid amount of fermention medium is 200mL/500mL, leave standstill and cultivated 60 hours, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is got the 0.5g wet thallus again with the deionized water wash of the bacterium of going out, is suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 10mM, reacted 1 hour, reaction solution is centrifugal to be got through efficient liquid phase chromatographic analysis, the about 1g/L of alpha-aminobutyric acid content.
Embodiment 2
This bacterial strain is after the agar slant culture-medium activation, transfer in the GYP seed culture medium, incubation time is 24 hours, seed culture fluid is inoculated in the sub-GYP fermention medium with 1% inoculum size, added a hydration L-Sodium Glutamate of 1% in the fermention medium, the liquid amount of fermention medium is 200mL/500mL, leave standstill and cultivated 60 hours, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is got the 0.5g wet thallus again with the deionized water wash of the bacterium of going out, is suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 20mM, reacted 2 hours, reaction solution is centrifugal to be got through efficient liquid phase chromatographic analysis, the about 2g/L of alpha-aminobutyric acid content.
Embodiment 3
This bacterial strain is after the agar slant culture-medium activation, transfer in the GYP seed culture medium, incubation time is 24 hours, seed culture fluid is inoculated in the GYP fermention medium with 1% inoculum size, adds a hydration L-Sodium Glutamate of 1% in the fermention medium, the liquid amount of fermention medium is 200mL/500mL, leave standstill and cultivated 60 hours, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is got the 0.5g wet thallus again with the deionized water wash of the bacterium of going out, is suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 40mM, reacted 3 hours, reaction solution is centrifugal to be got through efficient liquid phase chromatographic analysis, the about 4g/L of alpha-aminobutyric acid content.
Embodiment 4
This bacterial strain is after the agar slant culture-medium activation, transfer in the GYP seed culture medium, incubation time is 24 hours, seed culture fluid is inoculated in the GYP fermention medium with 1% inoculum size, adds a hydration L-Sodium Glutamate of 1% in the fermention medium, the liquid amount of fermention medium is 200mL/500mL, leave standstill and cultivated 60 hours, promptly get the fermented liquid of mycetome, thalline is by centrifugal (8000r/min, 5min) collection.Thalline after centrifugal is got the 0.5g wet thallus again with the deionized water wash of the bacterium of going out, is suspended in citric acid-Sodium phosphate dibasic buffer system of 25mL, L-Sodium Glutamate content is 60mM, reacted 5 hours, reaction solution is centrifugal to be got through efficient liquid phase chromatographic analysis, the about 6g/L of alpha-aminobutyric acid content.
Claims (1)
1. the method for a biosynthesizing γ-An Jidingsuan, it is characterized in that, deposit number is: the short lactobacillus of CGMCCNO.1306 (Lactobacillus brevis), after the agar slant culture-medium activation, transfer in GYP seed culture medium or MRS seed culture medium, cultivate after 10～30 hours, inoculum size with 0.5%～5% is inoculated in GYP or the MRS fermention medium, leave standstill under 25 ℃～35 ℃ and cultivate 48h～120h, promptly get the fermented liquid of mycetome, the thalline centrifugation is collected; Thalline after centrifugal is again with the deionized water wash of the bacterium of going out, get 0.25～2g wet thallus, be suspended in citric acid-Sodium phosphate dibasic buffer system of 15～50mL, L-Sodium Glutamate content is 5mM～60mM, reacted the centrifugal solution that contains γ-An Jidingsuan that promptly gets of reaction solution 1～10 hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510049187 CN1276087C (en) | 2005-03-07 | 2005-03-07 | Process for biologically synthesizing gamma-amino butyric acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510049187 CN1276087C (en) | 2005-03-07 | 2005-03-07 | Process for biologically synthesizing gamma-amino butyric acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1683544A CN1683544A (en) | 2005-10-19 |
| CN1276087C true CN1276087C (en) | 2006-09-20 |
Family
ID=35263044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510049187 Expired - Fee Related CN1276087C (en) | 2005-03-07 | 2005-03-07 | Process for biologically synthesizing gamma-amino butyric acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1276087C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104357431A (en) * | 2008-02-21 | 2015-02-18 | 巴斯夫欧洲公司 | Process for the production of gamma-aminobutyric acid |
| CN101724587B (en) * | 2009-09-10 | 2011-10-12 | 浙江师范大学 | Lactobacillus brevis L2 bacterial strain of high yield gamma-aminobutyrique and screening method and applications thereof |
| CN102174449B (en) * | 2011-03-04 | 2012-08-22 | 天津科技大学 | Method for producing high-yield gamma-propalanine and application thereof |
| CN102260720A (en) * | 2011-07-20 | 2011-11-30 | 贵州大学 | Method for producing gamma-aminobutyric acid by using Lactobacillus fructivorans |
| CN102559552B (en) * | 2012-01-09 | 2014-06-11 | 天津科技大学 | Production method and application of high-yield gamma-aminobutyric acid |
| CN102796779B (en) * | 2012-08-24 | 2013-11-20 | 南通励成生物工程有限公司 | Biological method for preparing gamma-aminobutyric acid |
| CN103966274B (en) * | 2013-02-05 | 2017-03-15 | 中国科学院海洋研究所 | A kind of method that gamma aminobutyric acid is produced as raw materials through biotransformation with aquatic products and its processing fent |
| CN108300742A (en) * | 2017-07-26 | 2018-07-20 | 南通励成生物工程有限公司 | A kind of method that current adding substrate enzyme prepares γ-aminobutyric acid |
| CN113061061A (en) * | 2021-02-19 | 2021-07-02 | 安徽丰乐农化有限责任公司 | Preparation method of chemical fertilizer rich in gamma-aminobutyric acid |
| CN114058653B (en) * | 2021-12-29 | 2024-02-09 | 南通励成生物工程有限公司 | Method for preparing gamma-aminobutyric acid by biological synthesis method |
-
2005
- 2005-03-07 CN CN 200510049187 patent/CN1276087C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1683544A (en) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1276087C (en) | Process for biologically synthesizing gamma-amino butyric acid | |
| CN1276077C (en) | Short lactobacillus producing gamma-aminobutyric acid and use thereof | |
| CN108034599B (en) | One plant of Lactobacillus brevis for efficiently synthesizing γ-aminobutyric acid from brewed spirit system | |
| CN105154358B (en) | A kind of method of bacillus and its simultaneous saccharification and fermentation production Pfansteihl | |
| CN1824783A (en) | Process for producing vanillic acid and vanillic aldehyde by fermentation transforming bran foots | |
| CN109355318A (en) | A kind of method of fermenting and producing butyric acid | |
| CN105316257B (en) | A method of it solving xylose lysine bacillus and its prepares 2-ketoacid | |
| CN1295342C (en) | Method for producing gamma-aminobutyric acid by control pH fermentation | |
| CN101805759A (en) | Method for producing L-lactic acid by taking cassava powder as material | |
| JP2024056920A (en) | Method for Producing 6-Hydroxydaidzein | |
| KR20020020905A (en) | Novel process for producing l-epi-2-inosose and novel process for producing epi-inositol | |
| CN100343385C (en) | Parvobacteria of high-yield 3-hydroxy-butanoic butanone | |
| CN117126898B (en) | Process for preparing valine by biotechnology | |
| CN1928071A (en) | Plant lactobacillus and method of biological preparing conjugated linoleic acid using the same | |
| JP5667976B2 (en) | Production method of organic acids | |
| CN111676170B (en) | Lactobacillus fermentum and application thereof in preparation of conjugated fatty acid | |
| CN102586343A (en) | Biocatalysis method for preparing pyruvic acid from L-alanine | |
| CN100526470C (en) | Preparation method of functional sweetener D-tatai sugar | |
| KR20120061470A (en) | Mutants of Lactobacillus paracasei with Improved Glucose Tolerance and Acid Tolerance and their Uses | |
| CN114958694A (en) | Lactobacillus rhamnosus for co-producing conjugated linoleic acid and gamma-aminobutyric acid and application thereof | |
| CN112501073B (en) | Bacillus marinus SWGC31 and culture method and application thereof | |
| CN106337064B (en) | Production method of L-malic acid | |
| CN1208454C (en) | Process for biologically synthesizing extracellular cholesterol oxidase from Brevibacterium and its transferred product, cholest-4-ene-3-one | |
| CN115181769B (en) | Method for improving yield of extracellular polysaccharide of tetracoccus halophilus | |
| CN114369558B (en) | Serratia marcescens and application thereof in naringinase production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060920 |